← back to search

Weizhen Huang

Shandong University · CN
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Pharmacology, Cyclophosphamide, Spleen, Immunosuppression, CD8, and Chemistry.
h-index
citations
161
works
3
NIH funding
primary concept
email

Recent publications

A phase II trial to evaluate the safety and efficacy of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, as a monotherapy in patients with advanced NSCLC.
Journal of Clinical Oncology 2025cited by 7position: middledoi
Protective Effect of Flavonoids from Ziziphus jujuba cv. Jinsixiaozao against Acetaminophen-Induced Liver Injury by Inhibiting Oxidative Stress and Inflammation in Mice
Molecules 2017cited by 68position: firstdoi
Immuno-enhancement effects of Yifei Tongluo Granules on cyclophosphamide-induced immunosuppression in Balb/c mice
Journal of Ethnopharmacology 2016cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Siying Li · Beihua University2 papers (2016–2017)Yongjie Wang · Shandong University2 papers (2016–2017)Zhongxi Zhao · Shandong University2 papers (2016–2017)Jun Yao · Jiangsu University1 papers (2025–2025) · 1 papers (2025–2025)Ang Li · Shandong University1 papers (2016–2016)Jie Li · Shanghai Jiao Tong University1 papers (2025–2025)Yan Yu · Shanghai University of Traditional Chinese Medicine1 papers (2025–2025)Ruoyu Wang · Ningbo University1 papers (2025–2025)Bolin Chen · Central South University1 papers (2025–2025)Weifeng Song · Fu Wai Hospital1 papers (2025–2025)Jin Zhou · Jiangsu University1 papers (2025–2025)Min Yang · Shandong University1 papers (2016–2016)Yueyue Sun · Shandong University1 papers (2017–2017)Jing Lou · Shenyang Pharmaceutical University1 papers (2025–2025)Qian Chu · Sun Yat-sen University Cancer Center1 papers (2025–2025)Qing Bu · Guangxi Medical University1 papers (2025–2025)Lin Wu · Harbin Medical University1 papers (2025–2025)Xiaoyan Jiang · Shandong University1 papers (2017–2017) · 1 papers (2025–2025)